Rapidly Progressive Pulmonary Alveolar Proteinosis Following Cryptococcal Infection: Case Report and Literature

Samuel Cartmel Brookes1,2, Alexandra Sadler1, Alexander Troelnikov3,4,5

  • 1Department of Thoracic Medicine Royal Adelaide Hospital Adelaide South Australia Australia.

Respirology Case Reports
|February 11, 2025
PubMed

Insights

This case study highlights a rare instance of autoimmune pulmonary alveolar proteinosis (PAP) rapidly developing after cryptococcal infection in a young Aboriginal Australian woman. It emphasizes the need for prompt recognition and intervention for this severe respiratory condition.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Immunology

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by surfactant accumulation in alveoli.
  • Cryptococcosis is a fungal infection often affecting the central nervous system and lungs.
  • Autoimmune PAP is linked to granulocyte-macrophage colony-stimulating factor antibodies, also associated with increased cryptococcosis risk.

Purpose of the Study:

  • To report a unique case of rapidly progressive autoimmune PAP following CNS cryptococcosis.
  • To underscore the importance of recognizing PAP in the Australian population.
  • To review the management and risks of bilateral whole lung lavage (WLL) in critically ill patients.

Main Methods:

  • Case report of a 24-year-old Aboriginal Australian woman.
  • Description of clinical presentation, diagnostic workup, and treatment.
  • Literature review on PAP and cryptococcal infections.

Main Results:

  • The patient presented with seizures due to CNS cryptococcosis, followed by rapid hypoxic respiratory failure from autoimmune PAP within weeks.
  • Urgent bilateral whole lung lavage (WLL) was performed while on venovenous-extracorporeal membrane oxygenation.
  • The case illustrates an unusually short interval between cryptococcal infection and PAP onset.

Conclusions:

  • Autoimmune PAP can develop rapidly after cryptococcosis, presenting a diagnostic and therapeutic challenge.
  • Bilateral WLL can be a critical intervention for severe PAP in ECMO-supported patients, despite associated risks.
  • Increased awareness of PAP, particularly in specific populations like Aboriginal Australians, is crucial.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
210
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
182
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220